[Antisense therapy]

[Article in Japanese]

Review

[Article in Japanese]

Y Mizushima et al. Nihon Naika Gakkai Zasshi. 1994.

. 1994 Sep 10;83(9):1688-91.

doi: 10.2169/naika.83.1688.

No abstract available

Similar articles

Retrovirally mediated delivery of angiotensin II type 1 receptor antisense in vitro and in vivo.
Wang H, Lu D, Reaves PY, Katovich MJ, Raizada MK. Wang H, et al. Methods Enzymol. 2000;314:581-90. doi: 10.1016/s0076-6879(99)14129-6. Methods Enzymol. 2000. PMID: 10565039
Antisense technology for cancer therapy: does it make sense?
Carter G, Lemoine NR. Carter G, et al. Br J Cancer. 1993 May;67(5):869-76. doi: 10.1038/bjc.1993.164. Br J Cancer. 1993. PMID: 8494718 Free PMC article. Review. No abstract available.
Antisense and sensibility.
Dove A. Dove A. Nat Biotechnol. 2002 Feb;20(2):121-4. doi: 10.1038/nbt0202-121. Nat Biotechnol. 2002. PMID: 11821852 No abstract available.
Fluorescence Characterization of Gold Modified Liposomes with Antisense N-myc DNA Bound to the Magnetisable Particles with Encapsulated Anticancer Drugs (Doxorubicin, Ellipticine and Etoposide).
Skalickova S, Nejdl L, Kudr J, Ruttkay-Nedecky B, Jimenez AM, Kopel P, Kremplova M, Masarik M, Stiborova M, Eckschlager T, Adam V, Kizek R. Skalickova S, et al. Sensors (Basel). 2016 Feb 25;16(3):290. doi: 10.3390/s16030290. Sensors (Basel). 2016. PMID: 26927112 Free PMC article.
DNA combination therapy to stop tumor growth.
Wickstrom E, Smith JB. Wickstrom E, et al. Cancer J Sci Am. 1998 May;4 Suppl 1:S43-7. Cancer J Sci Am. 1998. PMID: 9619270 Review. No abstract available.